Active substanceChondroitin sulfateChondroitin sulfate
Similar drugsTo uncover
  • Artogistan
    solution w / m 
    GROTEKS, LLC     Russia
  • ARTRA® Chondroitin
    capsules inwards 
    Unipharm, Inc.     USA
  • Arthravir®-Inkamparm®
    solution w / m 
    TRIVIUM-XXI, LLC     Russia
  • Arthradol®
    lyophilizate w / m 
    Inkamfarm, OOO     Russia
  • ARTRADOL®
    capsules inwards 
    TRIVIUM-XXI, LLC     Russia
  • Artrafic
    ointment externally 
    ATOLL, LLC     Russia
  • DRASTOP
    solution w / m 
  • Mukosat®
    solution w / m 
  • Mukosat®
    ointment externally 
       
  • Teraflex® Hondrokrem Forte
    cream externally 
    BAYER, AO     Russia
  • Hondroguard®
    solution w / m 
  • Chondroitin
    capsules inwards 
    VERTEKS, AO     Russia
  • Chondroitin
    gel externally 
    VERTEKS, AO     Russia
  • Chondroitin
    capsules inwards 
    ATOLL, LLC     Russia
  • Chondroitin sulfate
    lyophilizate w / m 
    ELLARA, LTD.     Russia
  • Chondroitin-Akos
    ointment externally 
    SYNTHESIS, OJSC     Russia
  • Chondroitin-Akos
    capsules inwards 
    SYNTHESIS, OJSC     Russia
  • Chondroitin sulfate
    solution w / m 
    Medimeks, ZAO     Russia
  • Chondroitin sulfate
    solution w / m 
    ELLARA, LTD.     Russia
  • Chondroitin sulfate
    lyophilizate w / m 
  • Chondroitin sulfate
    solution w / m 
    BIOSINTEZ, PAO     Russia
  • Chondroxide®
    ointment externally 
    NIZHFARM, JSC     Russia
  • Chondroxide®
    pills inwards 
    NIZHFARM, JSC     Russia
  • Chondroxide®
    gel externally 
    NIZHFARM, JSC     Russia
  • Chondrolon®
    lyophilizate w / m 
  • Dosage form: & nbsp
    Lyophilizate for the preparation of solution for intramuscular injection.
    Composition:
    One ampoule contains:
    Active substance - 100 mg chondroitin sulfate
    Description:White, porous, compacted into a tablet mass.
    Pharmacotherapeutic group:Regeneration of tissue stimulant.
    ATX: & nbsp

    M.01.A.X.25   Chondroitin sulfate

    Pharmacodynamics:
    Chondroitin sulfate is the main component of proteoglycans that make up the cartilaginous matrix together with collagen fibers. Has chondroprotective properties; inhibits the activity of enzymes that cause degradation of the articular cartilage; stimulates the production of proteoglycans by chondrocytes; strengthens metabolic processes in cartilage and subchondral bone; affects the phosphoric-calcium metabolism in the cartilaginous tissue, stimulates its regeneration, participates in the construction of the basic substance of bone and cartilaginous tissue. Has anti-inflammatory and analgesic properties,helps to reduce the release of inflammatory mediators and pain factors into synovial fluid through synovial and macrophage synovial membranes, suppresses the secretion of leukotriene B4 and prostaglandin E2.
    The drug contributes to the restoration of the cartilaginous surfaces of the joints, prevents the collapse of connective tissue; normalizes the production of articular fluid, which leads to better mobility of joints, reducing pain intensity.
    Pharmacokinetics:
    Chondroitin sodium sulfate is readily absorbed when administered intramuscularly. The maximum concentration is achieved 1 hour after the administration. The drug accumulates in the synovial fluid. It is excreted from the body mainly by the kidneys within 24 hours.

    Indications:Osteoarthritis of peripheral joints and spine.
    Contraindications:Hypersensitivity to chondroitin sulfate, a tendency to bleeding, thrombophlebitis, pregnancy, the period of breastfeeding (at the time of treatment, breast-feeding should be discontinued).
    Dosing and Administration:
    Intramuscularly, 1 ml every other day. Before use, the contents of the ampoule are dissolved in 1 ml of water for injection. With good tolerability, the dose is increased to 2 ml, starting with the fourth injection.The course of treatment is 25-35 injections. Repeated courses - after 6 months.
    The duration of repeated courses of treatment is set by the doctor. To achieve a stable clinical effect, at least 25 injections of chondroitin sulfate are necessary, with the effect persisting for many months after the end of the course of treatment. To prevent exacerbations, repeated courses of treatment are indicated.
    Side effects:Allergic reactions, hemorrhages at the injection site.
    Form release / dosage:
    Lyophilizate for the preparation of solution for intramuscular injection 100 mg.
    Packaging:
    Lyophilizate for the preparation of a solution for intramuscular injection of 100 mg in ampoules of 1 ml. For 100 mg in ampoules from neutral glass to 1 ml.
    5 ampoules in a contour mesh package made of a polyvinylchloride film without foil coating.
    For 1 or 2 contour packs with instructions for use and an ampoule scarifier (or without it) in a cardboard box. 5 ampoules or 10 ampoules with instructions for use and an ampoule scarifier (or without it) in a cardboard box with a corrugated liner.
    Storage conditions:In a dry, dark place at a temperature of 18 ° C to 22 ° C. Keep out of the reach of children.
    Shelf life:3 years.
    Terms of leave from pharmacies:On prescription
    Registration number:P N003406 / 01
    Date of registration:19.06.2009
    The owner of the registration certificate:ELLARA, LTD. ELLARA, LTD. Russia
    Manufacturer: & nbsp
    Information update date: & nbsp06.10.2015
    Illustrated instructions
      Instructions
      Up